SCHEMBL25845635

SCHEMBL25845635

COC[C@@H]1C[C@H](O[Si](C)(C)C(C)(C)C)[C@H](n2ccc(N)nc2=O)O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.41
THRB P10828 1/20 0.41
MTOR P42345 1/20 0.41
MDM2 Q00987 1/20 0.41
NCOA1 Q15788 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
PDE3A Q14432 3/20 0.38
CACNA1F O60840 2/20 0.38
ALB P02768 2/20 0.38
MAPT P10636 2/20 0.38
CACNA1D Q01668 2/20 0.38
CACNA1S Q13698 2/20 0.38
CACNA1C Q13936 2/20 0.38
NT5E P21589 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
POLB P06746 1/20 0.36
TSHR P16473 1/20 0.36
GLA P06280 1/20 0.36
ST6GAL1 P15907 2/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1738534 0.92 LMNA (0.41) LMNATHRBMTORMDM2NCOA1
SCHEMBL2816613 0.83 TYMP (0.41) LMNATHRBMTORMDM2NCOA1
SCHEMBL2816616 0.83 TYMP (0.41) LMNATHRBMTORMDM2NCOA1
SCHEMBL15158164 0.81 LMNA (0.51) LMNATHRBMTORMDM2NCOA1
SCHEMBL15788413 0.81 LMNA (0.51) LMNATHRBMTORMDM2NCOA1
SCHEMBL19932389 0.81 LMNA (0.46) LMNATHRBMTORMDM2NCOA1
SCHEMBL12313846 0.80 LMNA (0.38) LMNATHRBMTORMDM2NCOA1
SCHEMBL8887597 0.78 LMNA (0.47) LMNATHRBMTORMDM2NCOA1
SCHEMBL8887594 0.78 LMNA (0.47) LMNATHRBMTORMDM2NCOA1
SCHEMBL2838277 0.77 THRB (0.34) THRBNT5EPOLBP2RY2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3730504-B1 CYTARABINE PRODRUG NUCLEOSIDE CYCLIC PHOSPHATE COMPOUND BASED ON LIVER-SPECIFIC DELIVERY AND USE ZHEJIANG PALO ALTO PHARMACEUTICALS INC (CN) 2023-07-12 EP disclosed